Matches in SemOpenAlex for { <https://semopenalex.org/work/W2132526261> ?p ?o ?g. }
- W2132526261 endingPage "6" @default.
- W2132526261 startingPage "2943" @default.
- W2132526261 abstract "The age standardised incidence rate (ASR) of breast cancer in Malaysia which is a high middle- income country is similar to Indonesia, a low middle-income country. (Globocan 2008) It is however unknown whether the presentation of breast cancer differs between these two countries.We compared the stage, age at presentation, and pathological characteristics of breast cancer between two tertiary hospitals in Indonesia and Malaysia; Dharmais Cancer Centre (DCC), which is the national cancer referral centre in Indonesia, and University Malaya Medical Centre (UMMC), which is an academic hospital with established breast oncology services in Kuala Lumpur. One thousand, one hundred and fourteen consecutive women (477 in UMMC: 637 in DCC) who were newly diagnosed with breast cancer between January and December, 2010 were included. Patient's age, TNM stage at presentation, and pathological characteristics were compared. Estrogen receptor (ER) and progesterone receptor (PR) were considered positive if 10% or greater of invasive cell nuclei were stained while HER2 was considered positive with an immunohistochemistry staining intensity of 3+ . Logistic regression analyses were performed to identify differences.Median age at diagnosis was 52 years in UMMC and 47 years in DCC, whereby patients in DCC were more likely to be very young at diagnosis (aged < 35 years) compared to their counterparts in UMMC (Odds ratio (OR): 2.09; 95%CI: 1.32-3.31). Approximately one third of patients in UMMC presented with TNM stage III or IV, compared to 63% in DCC. Patients in DCC were three times more likely to present with metastatic breast cancer compared to patients in UMMC (OR: 3.01; 95% CI: 2.02-4.48). The percentage of low grade tumours in DCC was higher than in UMMC (28% vs 11% respectively), and the difference persisted even after multivariate adjustment. Although the frequency of ER and PR positivity appeared to be higher in UMMC (65% and 55% respectively) compared to DCC (48% and 40% respectively), these differences were not statistically significant following adjustment for age, stage, HER2 status and grade. The frequency of HER2 positivity was 45% in DCC compared to 26% in UMMC, and remained significantly higher even after multivariate adjustment (multivariate OR:1.76; 95%CI:1.25-2.47, in DCC compared to UMMC). The proportion of triple negative breast cancer was however similar in the two centres (19% in UMMC vs 21% in DCC).Indonesian women with breast cancer seem to present at a younger age and at later stages compared to Malaysian women. Their tumors were more likely to be of low grade and HER2 positive, even after adjustment for other factors, while hormone receptor positivity proved similar in the two groups. The higher HER2 positivity rate in Indonesian patients warrants further study." @default.
- W2132526261 created "2016-06-24" @default.
- W2132526261 creator A5012975360 @default.
- W2132526261 creator A5030353869 @default.
- W2132526261 creator A5037287504 @default.
- W2132526261 creator A5037338885 @default.
- W2132526261 creator A5045599850 @default.
- W2132526261 creator A5047315195 @default.
- W2132526261 creator A5062032318 @default.
- W2132526261 creator A5087872892 @default.
- W2132526261 creator A5090586135 @default.
- W2132526261 date "2011-01-01" @default.
- W2132526261 modified "2023-09-27" @default.
- W2132526261 title "Comparison of breast cancer in Indonesia and Malaysia--a clinico-pathological study between Dharmais Cancer Centre Jakarta and University Malaya Medical Centre, Kuala Lumpur." @default.
- W2132526261 cites W1770811349 @default.
- W2132526261 cites W1782762906 @default.
- W2132526261 cites W1966173991 @default.
- W2132526261 cites W2005397367 @default.
- W2132526261 cites W2007113211 @default.
- W2132526261 cites W2018661569 @default.
- W2132526261 cites W2134484332 @default.
- W2132526261 cites W2134922322 @default.
- W2132526261 cites W2137529977 @default.
- W2132526261 cites W2137853125 @default.
- W2132526261 cites W2139772140 @default.
- W2132526261 cites W2153344026 @default.
- W2132526261 cites W2155715818 @default.
- W2132526261 cites W2159585546 @default.
- W2132526261 cites W2170527280 @default.
- W2132526261 cites W2408993401 @default.
- W2132526261 cites W2415336225 @default.
- W2132526261 cites W2551622694 @default.
- W2132526261 cites W267005183 @default.
- W2132526261 cites W2410323488 @default.
- W2132526261 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22393968" @default.
- W2132526261 hasPublicationYear "2011" @default.
- W2132526261 type Work @default.
- W2132526261 sameAs 2132526261 @default.
- W2132526261 citedByCount "32" @default.
- W2132526261 countsByYear W21325262612013 @default.
- W2132526261 countsByYear W21325262612014 @default.
- W2132526261 countsByYear W21325262612015 @default.
- W2132526261 countsByYear W21325262612016 @default.
- W2132526261 countsByYear W21325262612017 @default.
- W2132526261 countsByYear W21325262612018 @default.
- W2132526261 countsByYear W21325262612019 @default.
- W2132526261 countsByYear W21325262612020 @default.
- W2132526261 countsByYear W21325262612021 @default.
- W2132526261 countsByYear W21325262612022 @default.
- W2132526261 countsByYear W21325262612023 @default.
- W2132526261 crossrefType "journal-article" @default.
- W2132526261 hasAuthorship W2132526261A5012975360 @default.
- W2132526261 hasAuthorship W2132526261A5030353869 @default.
- W2132526261 hasAuthorship W2132526261A5037287504 @default.
- W2132526261 hasAuthorship W2132526261A5037338885 @default.
- W2132526261 hasAuthorship W2132526261A5045599850 @default.
- W2132526261 hasAuthorship W2132526261A5047315195 @default.
- W2132526261 hasAuthorship W2132526261A5062032318 @default.
- W2132526261 hasAuthorship W2132526261A5087872892 @default.
- W2132526261 hasAuthorship W2132526261A5090586135 @default.
- W2132526261 hasConcept C120665830 @default.
- W2132526261 hasConcept C121332964 @default.
- W2132526261 hasConcept C121608353 @default.
- W2132526261 hasConcept C126322002 @default.
- W2132526261 hasConcept C144133560 @default.
- W2132526261 hasConcept C146357865 @default.
- W2132526261 hasConcept C151730666 @default.
- W2132526261 hasConcept C162853370 @default.
- W2132526261 hasConcept C207886595 @default.
- W2132526261 hasConcept C2776135927 @default.
- W2132526261 hasConcept C29456083 @default.
- W2132526261 hasConcept C3018591125 @default.
- W2132526261 hasConcept C512399662 @default.
- W2132526261 hasConcept C530470458 @default.
- W2132526261 hasConcept C61511704 @default.
- W2132526261 hasConcept C71924100 @default.
- W2132526261 hasConcept C86803240 @default.
- W2132526261 hasConceptScore W2132526261C120665830 @default.
- W2132526261 hasConceptScore W2132526261C121332964 @default.
- W2132526261 hasConceptScore W2132526261C121608353 @default.
- W2132526261 hasConceptScore W2132526261C126322002 @default.
- W2132526261 hasConceptScore W2132526261C144133560 @default.
- W2132526261 hasConceptScore W2132526261C146357865 @default.
- W2132526261 hasConceptScore W2132526261C151730666 @default.
- W2132526261 hasConceptScore W2132526261C162853370 @default.
- W2132526261 hasConceptScore W2132526261C207886595 @default.
- W2132526261 hasConceptScore W2132526261C2776135927 @default.
- W2132526261 hasConceptScore W2132526261C29456083 @default.
- W2132526261 hasConceptScore W2132526261C3018591125 @default.
- W2132526261 hasConceptScore W2132526261C512399662 @default.
- W2132526261 hasConceptScore W2132526261C530470458 @default.
- W2132526261 hasConceptScore W2132526261C61511704 @default.
- W2132526261 hasConceptScore W2132526261C71924100 @default.
- W2132526261 hasConceptScore W2132526261C86803240 @default.
- W2132526261 hasIssue "11" @default.
- W2132526261 hasLocation W21325262611 @default.
- W2132526261 hasOpenAccess W2132526261 @default.
- W2132526261 hasPrimaryLocation W21325262611 @default.